Company receives multimillion dollar grant to focus on post-stroke recovery; Proven technology in 700 patients granted Breakthrough Device designation from the FDA EFFINGHAM, Ill.--(BUSINESS ...
Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...
A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
FILE - The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. (AP Photo/Ted Shaffrey, File) (Ted Shaffrey, Copyright 2024 The Associated ...
Guanosine, a purine nucleoside, has emerged as a potent modulator within the central nervous system (CNS), contributing to neuroprotection through a diverse array of mechanisms. It plays a critical ...
Racism, discrimination, and social determinants of health have contributed to clear disparities in health and health outcomes, particularly in central nervous system (CNS) disorders. Recognizing the ...
This color-coded graphic shows different populations of cells in the mouse brain, each one targeted by one of the genetic tools developed by scientists at the Allen Institute and other institutions.
The central nervous system (CNS) critically depends on the integrity of oligodendrocytes, specialised glial cells responsible for the formation and maintenance of myelin sheaths. Myelin not only ...
Each part of the nervous system uses internal checks and balances to regulate its activity, responding to various factors like mood, health status, and the external environment.¹ These regulatory ...
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said Monday ...
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
Alicia Andrews, 21, sits during pre-trial hearing of Charles "Julio Foolio" Jones murder trial. Read full article: Jury selection begins Monday in trial of woman accused of stalking Jacksonville ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results